NWSMU named after I.I. Mechnikova, Saint-Petersburg; First Pavlov State Medical University of St. Petersburg, Russia.
Georgian Med News. 2024 May(350):54-56.
Hyperhomocysteinaemia (elevated blood levels of the amino acid homocysteine) attracted the interest of researchers in the middle of the 20th century. At first. Butz and du Vigneaud in 1932 described a disorder of methionine metabolism in children, which was manifested by homocysteinuria (homocysteine is not normally detected in the urine). In 1962 Cavon and Neil found that homocysteinuria in children is associated with a defect in cystathione-B-synthase and manifests early development of atherosclerosis. It is quite possible that these facts would have remained unnoticed by the medical community had it not been for further research by Kilmer McQuilley, a professor in the Department of Pathology at Harvard Medical School. The scientist suggested that while high concentrations of homocysteine could damage blood vessels in young people, it was likely that lower concentrations of homocysteine, acting over a longer period of time, could cause cardiovascular disease in adults. Subsequent studies enabled him to formulate the "homocysteine" theory of atherosclerosis and to publish its main points in 1969. Hyperhomocysteinaemia in young men has been shown to cause damage to the endothelium of blood vessels, and consequently males face the consequent equally global problem of developing erectile dysfunction. Erection is a state regulated by a neurovascular process, characterized by blood filling of the cavernous bodies, provided by neural and humoral mechanisms occurring at different levels of the nervous system. Erectile dysfunction (ED) refers to the inability to achieve and maintain an erection at a level necessary to ensure satisfactory sexual intercourse, Although ED is not life-threatening. it is a serious psychological and physiological problem, and it has now been shown to correlate the quality of intimate life with general health and even with life expectancy, In the USA alone, ED is reported in 20-30 million men, and the prevalence of these disorders increases with age. A study of the homocysteine level of multidisciplinary hospital patients was used as the main marker. The work used laboratory and statistical research methods, as well as analysis and synthesis methods. Using patient analyses, laboratory and statistical data, it has been shown that hyperhomosysteinaemia is one of the molecular mechanisms in the development of erectile dysfunction.
高同型半胱氨酸血症(血液中氨基酸同型半胱氨酸水平升高)引起了 20 世纪中期研究人员的兴趣。起初,Butz 和 du Vigneaud 于 1932 年描述了一种儿童蛋氨酸代谢紊乱,其特征是同型半胱氨酸尿症(尿液中通常检测不到同型半胱氨酸)。1962 年,Cavon 和 Neil 发现儿童同型半胱氨酸尿症与胱硫醚-β-合酶缺陷有关,并表现出动脉粥样硬化的早期发展。如果不是哈佛医学院病理学系教授 Kilmer McQuilley 的进一步研究,这些事实很可能不会引起医学界的注意。这位科学家认为,虽然同型半胱氨酸浓度升高可能会损害年轻人的血管,但浓度较低的同型半胱氨酸在较长时间内作用,可能会导致成年人患心血管疾病。随后的研究使他能够提出动脉粥样硬化的“同型半胱氨酸”理论,并于 1969 年发表了其主要观点。已经证明,年轻男性的高同型半胱氨酸血症会导致血管内皮损伤,因此男性面临着随之而来的同样全球性的勃起功能障碍问题。勃起是一种由神经血管过程调节的状态,其特征是海绵体的血液充盈,由发生在神经系统不同水平的神经和体液机制提供。勃起功能障碍(ED)是指无法达到和维持足以确保满意性交的勃起水平,尽管 ED 不会危及生命,但它是一个严重的心理和生理问题,现在已经表明,它与亲密生活的质量与整体健康甚至与预期寿命相关,仅在美国,就有 2000 万至 3000 万男性报告患有 ED,这些疾病的患病率随着年龄的增长而增加。多学科医院患者的同型半胱氨酸水平被用作主要标志物。这项工作使用了实验室和统计研究方法,以及分析和综合方法。通过对患者分析、实验室和统计数据的研究,已经表明高同型半胱氨酸血症是勃起功能障碍发展的分子机制之一。